Lichen sclerosus -: Present-day hormonal therapy

被引:3
|
作者
Küng, F [1 ]
机构
[1] Univ Zurich Hosp, Dept Frauenheilkunde, Klin Endokrinol, CH-8091 Zurich, Switzerland
来源
关键词
lichen sclerosus; therapy; testosterone; clobetasol;
D O I
10.1159/000022325
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Several treatment modalities of lichen sclerosus have been described, Topical testosterone (2%) has been the therapy of choice with improvement of symptoms in 67-100% of the patients. Newer placebo-controlled studies report success rates for testosterone of 20% which is not much higher than for placebo (10%). Treatment with the very potent steroidlike clobetasol 0.05% has been shown to be much more effective with success rates of up to 75%, while corticosteroid-related side effects like skin atrophy have not been a major problem. Copyright (C) 2000 S. Karger AG, Basel.
引用
收藏
页码:29 / 32
页数:4
相关论文
共 50 条